Abilify Gambling Lawsuit 2017-10-16T00:03:28+00:00

Abilify Gambling Lawsuit News: Use of the antipsychotic Abilify may result in impulse control problems, including compulsive gambling! Since being brought to market in 2002, studies have linked Abilify to gambling addiction and other compulsive behaviors, including sexual addictions, compulsive shopping and compulsive eating. In May 2016, the U.S. Food & Drug Administration (FDA) announced that stronger warnings regarding these issues would be added to the Abilify label and related medications. However, Abilify lawsuit plaintiffs claim that these warnings came too late for individuals whose lives and finances were allegedly ruined by an Abilify gambling problem.

Abilify Gambling Side Effect Lawsuit

You could be entitled to significant financial compensation if you or a loved one sustained gambling losses and other damages that could be linked to the use of Abilify. The law firm of Wright & Schulte LLC is committed to ensuring that the victims of defective prescription drugs obtain the justice they deserve, and our attorneys are now offering free Abilify Gambling Lawsuit legal reviews to anyone who experienced compulsive behaviors while taking Abilify. If you are interested in filing an Abilify gambling lawsuit, please contact our office today to learn more about your possible legal options.

Abilify And Gambling Side Effect

Abilify belongs to a class of medications called partial dopamine receptor agonists, and is commonly prescribed for the treatment of schizophrenia, bipolar disorder, major depressive disorders, irritability, aggression, mood swings and other psychological problems. A number of other drugs also contain aripiprazole as an active ingredient, including Abilify Maintena, Aristada, and generics.

Abilify Compulsive Gambling Side Effect Studies

Dopamine is a neurotransmitter that helps control the brain’s reward and pleasure center. In 2009, researchers at the Mayo Clinic warned that dopamine agonists could be linked to impulse control problems, including gambling addictions and hypersexuality.

In 2011 the British Journal of Psychiatry published a Abilify study that examined three patients who suffered from compulsive gambling while taking the drug abilify. A different anti-depressant was prescribed for the patients besides Abilify. The researchers reported that after 6 months all three patients had not resumed gambling while on the new drug.[http://bjp.rcpsych.org/content/199/2/158 – BJPsych -Pathological gambling and the treatment of psychosis with aripiprazole: case reports 2011]

A study published in JAMA Internal Medicine in 2014 also suggested that use of Abilify could be related to gambling addictions, risky sexual behavior and compulsive shopping. Researchers from the Institute for Safe Medication Practices (ISMP), Harvard Medical School and the University of Ottawa evaluated a class of drugs ( that includes Abilify ) known as dopamine receptor agonists, which are most commonly prescribed for treatment of Parkinson’s disease, restless leg syndrome, Tourette’s Syndrome, Autism, Depression, Schizophrenia, hyperprolactinemia and Bi-Polar disorder. Their findings showed a link between these types of drugs and compulsive gambling and impulse control problems.[http://jamanetwork.com/journals/jamainternalmedicine/fullarticle/1916909 – Jama -Reports of Pathological Gambling, Hypersexuality, and Compulsive Shopping Associated With Dopamine Receptor Agonist Drugs 2014]

A third study in 2014 published in the National Center for Biotechnology Information showed that 7 out of 8 patients taking aripiprazole may develop a pathological gambling problem[https://www.ncbi.nlm.nih.gov/pubmed/24315783 – NCBI -Aripiprazole: a new risk factor for pathological gambling? A report of 8 case reports 2014]

2016 Abilify Label Update

In May 2016, the FDA announced that new information regarding compulsive behaviors would be added to the labels of Abilify and related medications. Although pathological gambling was already listed as a reported side effect in the current drug labels, the agency said the description did not entirely reflect the nature of the impulse-control risk identified by a recent review.

According to the FDA, that review found 184 case reports in which there was an association between aripiprazole use and impulse-control problem during the 13 years since Abilify was approved in November 2002. Pathological gambling was the most common (164 cases), but other compulsive behaviors including compulsive eating, spending or shopping, and sexual behaviors were also reported. In most cases, the affected patients had no prior history of compulsive behaviors, and began experiencing urges shortly after they initiated treatment with aripiprazole. Within days to weeks of reducing the dose or discontinuing aripiprazole, these uncontrollable urges stopped, according to the FDA.

The new Abilify label debuted in August 2016. The label now advises that:

  • Patients may not be able to recognize that their compulsive behavior is unusual.
  • Healthcare providers should specifically ask patients about any new or intense urges to gamble, shop, eat, or have sex.
  • Abilify treatment should be stopped or the dose reduced in patients who experience uncontrollable urges.

Abilify Gambling Lawsuits And Litigation

Dozens of Abilify Gambling Lawsuits have been filed in U.S. courts on behalf of individuals who allegedly experienced compulsive gambling and other impulse control issues while using the medication. In October 2016, all federal Abilify gambling lawsuit cases were centralized in the U.S. District Court, Middle District of Florida, in a multidistrict litigation in order to undergo coordinated pretrial proceedings. The Abilify litigation is expected to grow to include hundreds of similar Abilify Gambling Lawsuits.

Wright & Schulte LLC is offering free Abilify Gambling Lawsuit legal consultations to anyone who may have experienced an Abilify gambling problem. To learn more about filing an Abilify gambling lawsuit, please contact the firm today by completing the online form on the right, or call toll free, 1-800-399-0795.


For a FREE Case Review, please complete the form. Our attorneys will review your case promptly and contact you to discuss your legal rights and options.

We maintain the strict confidential privacy of your message. We do not transfer your personal information to any third party. By submitting this form with your information, you give Wright & Schulte LLC permission to confidentially contact you. Information entered in the form will be used solely for informational purposes to assist in your case investigation


For a free, no obligation legal evaluation of your case, simply fill out the online form on the right, or give Wright & Schulte LLC a call, toll-free, at 1-800-399-0795.